|
Stock-Based Compensation (Tables)
|
6 Months Ended |
|
Jun. 30, 2013
|
| Stock-Based Compensation [Abstract] |
|
| Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs |
As more fully discussed in Note 6 to the Consolidated Financial Statements included in EOG's 2012 Annual Report, EOG maintains various stock-based compensation plans. Stock-based compensation expense is included on the Consolidated Statements of Income and Comprehensive Income based upon the job function of the employees receiving the grants as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gathering and Processing Costs | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | General and Administrative | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Weighted Average Fair Values and Valuation Assumptions |
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants during the six-month periods ended June 30, 2013 and 2012 are as follows:
| | Stock Options/SARs | | | ESPP | | | | Six Months Ended | | | Six Months Ended | | | | June 30, | | | June 30, | | | | 2013 | | | 2012 | | | 2013 | | | 2012 | | | | | | | | | | | | | | | Weighted Average Fair Value of Grants | | $ | 38.66 | | | $ | 35.65 | | | $ | 28.80 | | | $ | 28.24 | | Expected Volatility | | | 35.82 | % | | | 39.97 | % | | | 29.95 | % | | | 46.42 | % | Risk-Free Interest Rate | | | 0.48 | % | | | 0.49 | % | | | 0.12 | % | | | 0.06 | % | Dividend Yield | | | 0.6 | % | | | 0.7 | % | | | 0.6 | % | | | 0.6 | % | Expected Life | | 5.5 yrs | | | 5.5 yrs | | | 0.5 yrs | | | 0.5 yrs | |
|
| Stock Options and SARs Transactions |
The following table sets forth stock option and SAR transactions for the six-month periods ended June 30, 2013 and 2012 (stock options and SARs in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ) | | | | | | | | ) | | | | | | | | | ) | | | | | | | | ) | | | | | Outstanding at June 30 (2) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Vested or Expected to Vest (3) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Exercisable at June 30 (4) | | | | | | | | | | | | | | | | |
| (1) | The total intrinsic value of stock options/SARs exercised for the six months ended June 30, 2013 and 2012 was $62.1 million and $45.4 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. |
| (2) | The total intrinsic value of stock options/SARs outstanding at June 30, 2013 and 2012 was $219.5 million and $147.8 million, respectively. At June 30, 2013 and 2012, the weighted average remaining contractual life was 4.1 years and 3.4 years, respectively. |
| (3) | The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2013 and 2012 was $211.7 million and $146.7 million, respectively. At June 30, 2013 and 2012, the weighted average remaining contractual life was 4.1 years and 3.3 years, respectively. |
| (4) | The total intrinsic value of stock options/SARs exercisable at June 30, 2013 and 2012 was $116.7 million and $134.3 million, respectively. At June 30, 2013 and 2012, the weighted average remaining contractual life was 2.6 years and 2.0 years, respectively. |
|
| Restricted Stock and Restricted Stock Unit Transactions |
The following table sets forth restricted stock and restricted stock units transactions for the six-month periods ended June 30, 2013 and 2012 (shares and units in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | ) | | | | | | | | ) | | | | | | | | | ) | | | | | | | | ) | | | | | Outstanding at June 30 (2) | | | | | | | | | | | | | | | | |
| (1) | The total intrinsic value of restricted stock and restricted stock units released for the six months ended June 30, 2013 and 2012 was $35.4 million and $55.7 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date restricted stock and restricted stock units are released. |
| (2) | The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2013 and 2012 was $491.9 million and $357.3 million, respectively. |
|